Market Overview:
The global neuromuscular stimulator market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing geriatric population, and technological advancements in neuromuscular stimulators. Based on type, the global neuromuscular stimulator market is segmented into spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. SCS held the largest share of the global neuromuscular stimulator market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its ability to treat various chronic diseases such as pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, among others. Based on application, the global neuromuscular stimulator market is segmented into pain management, Parkinson's disease treatment , urinary and fecal incontinence treatment , epilepsy treatment , gastroparesis treatment , and others . Pain management held the largest share of the global neuromuscular stimulator market in 2017 . This can be attributed to increasing awareness about various pain relief therapies among patients suffering from chronic pain conditions .
Product Definition:
Neuromuscular stimulators are devices that send electrical signals to muscles to help them contract. They are used to improve muscle function, reduce pain, and improve blood circulation.
Spinal Cord Stimulation (SCS):
Spinal cord stimulation is a procedure wherein the nerve fibers of the spinal cord are stimulated by an electrode placed on or near to the surface of the spinal cord. The technique is used for various purposes such as treatment of chronic pain, severe muscle spasms, and providing relief from symptoms associated with multiple sclerosis.
Gastric Electric Stimulation (GES):
The gastric electric stimulation is a procedure wherein the electrical signal is sent to the stomach through electrodes placed on either side of the lower gastrointestinal tract. The treatment helps in decreasing nausea and vomiting caused due to cancer, medication-induced nausea and motion sickness. This device works by decreasing or eliminating symptoms of anticipatory emesis (vomiting before meals), postprandial emesis (after meals), and delayed meal emptying time.
Application Insights:
The pain management segment dominated the global market in 2017. Neuromuscular stimulators are used for the treatment of chronic pain due to spinal cord injuries, failed back surgery, and other causes. The increasing prevalence of chronic diseases, especially cancer and diabetes is expected to drive demand for these devices over the forecast period.
Neuromuscular stimulators are also used for non-chronic pains such as acute lower back pains or neck pains caused by car accidents or sports injuries. Increasing awareness about these devices among patients suffering from acute pain is expected to further propel their adoption during the forecast period.
On the other hand, Parkinson's disease held a significant share in 2017 owing to an increase in research initiatives by government bodies and private institutions aimed at developing effective therapies for this condition using neuromuscular stimulator machines.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of patients suffering from neurodegenerative disorders, such as Parkinson's disease (PD) and epilepsy, which are major drivers for regional growth. Moreover, increasing R&D investments by prominent players and their efforts to commercialize products at an early stage are also responsible for this dominance. For instance, in May 2018, Becton Dickinson and Company launched PD-7 system that is designed for home use with computerized patient monitoring software.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2020, owing to the increase in life expectancy and the growth in the number of people aged 65 years and above. This will result in an increase in demand for neuromuscular stimulators as these devices are used for treating various age-related disorders such as sarcopenia, Parkinson’s disease, Alzheimer’s disease, and dementia.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as obesity, diabetes mellitus, cardiovascular diseases (CVDs), and respiratory disorders is increasing globally due to changing lifestyles and dietary habits. This has led to an increase in demand for neuromuscular stimulators as they are used for treating various chronic conditions such as obesity-associated type 2 diabetes mellitus (T2DM), hypertension (HTN), CVDs, asthma, COPD etc.
- Technological advancements: The development of new technologies has led to the introduction of novel neuromuscular stimulator devices that are more effective than traditional devices in terms of treatment outcomes and patient compliance rates. These technological advancements are helping fuel market growth by providing manufacturers with opportunities to develop innovative products that can address specific needs/ requirements of patients/ healthcare providers/ payers etcetera . For instance , In March 2017 , NeuroMetrix announced the launch its Quell 4 wearable device which
Scope Of The Report
Report Attributes
Report Details
Report Title
Neuromuscular Stimulators Market Research Report
By Type
Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Others
By Application
Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Others
By Companies
Medtronic, Boston Scientific, Abbott, LiveNova(Cyberonics), Nevro, Inspire Medical Systems, NeuroPace, Autonomic Technologies, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Neuromuscular Stimulators Market Report Segments:
The global Neuromuscular Stimulators market is segmented on the basis of:
Types
Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Abbott
- LiveNova(Cyberonics)
- Nevro
- Inspire Medical Systems
- NeuroPace
- Autonomic Technologies
- Medtronic
Highlights of The Neuromuscular Stimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spinal Cord Stimulation (SCS)
- Gastric Electric Stimulation (GES)
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Others
- By Application:
- Pain Management
- Parkinson's Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Gastroparesis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neuromuscular Stimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A neuromuscular stimulator is a medical device that stimulates the nerves to improve muscle function.
Some of the major players in the neuromuscular stimulators market are Medtronic, Boston Scientific, Abbott, LiveNova(Cyberonics), Nevro, Inspire Medical Systems, NeuroPace, Autonomic Technologies, Medtronic.
The neuromuscular stimulators market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neuromuscular Stimulators Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neuromuscular Stimulators Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neuromuscular Stimulators Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neuromuscular Stimulators Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neuromuscular Stimulators Market Size & Forecast, 2020-2028
4.5.1 Neuromuscular Stimulators Market Size and Y-o-Y Growth
4.5.2 Neuromuscular Stimulators Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Spinal Cord Stimulation (SCS)
5.2.2 Gastric Electric Stimulation (GES)
5.2.3 Deep Brain Stimulation (DBS)
5.2.4 Sacral Nerve Stimulation (SNS)
5.2.5 Vagus Nerve Stimulation (VNS)
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pain Management
6.2.2 Parkinson's Disease
6.2.3 Urinary and Fecal Incontinence
6.2.4 Epilepsy
6.2.5 Gastroparesis
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neuromuscular Stimulators Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neuromuscular Stimulators Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Spinal Cord Stimulation (SCS)
9.6.2 Gastric Electric Stimulation (GES)
9.6.3 Deep Brain Stimulation (DBS)
9.6.4 Sacral Nerve Stimulation (SNS)
9.6.5 Vagus Nerve Stimulation (VNS)
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pain Management
9.10.2 Parkinson's Disease
9.10.3 Urinary and Fecal Incontinence
9.10.4 Epilepsy
9.10.5 Gastroparesis
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Spinal Cord Stimulation (SCS)
10.6.2 Gastric Electric Stimulation (GES)
10.6.3 Deep Brain Stimulation (DBS)
10.6.4 Sacral Nerve Stimulation (SNS)
10.6.5 Vagus Nerve Stimulation (VNS)
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pain Management
10.10.2 Parkinson's Disease
10.10.3 Urinary and Fecal Incontinence
10.10.4 Epilepsy
10.10.5 Gastroparesis
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Spinal Cord Stimulation (SCS)
11.6.2 Gastric Electric Stimulation (GES)
11.6.3 Deep Brain Stimulation (DBS)
11.6.4 Sacral Nerve Stimulation (SNS)
11.6.5 Vagus Nerve Stimulation (VNS)
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pain Management
11.10.2 Parkinson's Disease
11.10.3 Urinary and Fecal Incontinence
11.10.4 Epilepsy
11.10.5 Gastroparesis
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Spinal Cord Stimulation (SCS)
12.6.2 Gastric Electric Stimulation (GES)
12.6.3 Deep Brain Stimulation (DBS)
12.6.4 Sacral Nerve Stimulation (SNS)
12.6.5 Vagus Nerve Stimulation (VNS)
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pain Management
12.10.2 Parkinson's Disease
12.10.3 Urinary and Fecal Incontinence
12.10.4 Epilepsy
12.10.5 Gastroparesis
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Spinal Cord Stimulation (SCS)
13.6.2 Gastric Electric Stimulation (GES)
13.6.3 Deep Brain Stimulation (DBS)
13.6.4 Sacral Nerve Stimulation (SNS)
13.6.5 Vagus Nerve Stimulation (VNS)
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pain Management
13.10.2 Parkinson's Disease
13.10.3 Urinary and Fecal Incontinence
13.10.4 Epilepsy
13.10.5 Gastroparesis
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neuromuscular Stimulators Market: Competitive Dashboard
14.2 Global Neuromuscular Stimulators Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Boston Scientific
14.3.3 Abbott
14.3.4 LiveNova(Cyberonics)
14.3.5 Nevro
14.3.6 Inspire Medical Systems
14.3.7 NeuroPace
14.3.8 Autonomic Technologies
14.3.9 Medtronic
